Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Wolf and Dr. Rubinek team at Tel Aviv University and Sourasky Medical Center REHOVOT, Israel, April 16, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Pipeline and key clinical candidates for these companies: Galmed is a clinical stage biopharmaceutical company focused on the development of Aramchol for liver and fibro-inflammatory diseases. The ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing its first drug asset from the deal. Lilly will pay up to $415 million in ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees. In the ...

View today's HOB Biotech Group Corp Ltd stock price and latest 688656 news and analysis. Create real-time notifications to follow any changes in the live stock price.

Fermenta Biotech, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹294.05. The stock has experienced fluctuations today ...

SPARTANBURG COUNTY, S.C. (WSPA) – A biotech research and development center announced that they have plans to set up operations in Spartanburg County. Related video: $19M childcare campus coming ...

The biotech group counts former Fortescue Metals and WorleyParsons executive Peter Meurs as its biggest shareholder, with a 13.5 per cent stake. Former Fortescue Metals Group and WorleyParsons ...

Pliant Therapeutics, a South San Francisco biotech company developing treatments for fibrosis, is slashing its staff after halting a crucial study over safety concerns. This layoff round arrives ...